Global Polymer-Based Drug Delivery Market

Polymer-Based Drug Delivery Comprehensive Study by Type (Natural polymers (such as cellulose, starch), Semi-synthetic polymers (such as cellulose derivatives), Synthetic polymers (such as polyethene, polyester)), Application (Medical Research Center, Pharmaceutical Factory, Others), Releasing Pattern (Diffusion-controlled systems, Externally triggered systems, Chemically controlled (biodegradable) systems, Solvent-activated systems) Players and Region - Global Market Outlook to 2026

Polymer-Based Drug Delivery Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Polymer-Based Drug Delivery?
Polymers provide controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. In this, biodegradable polymers are widely used in drug delivery as they can be degraded to non-toxic monomers inside the body. Proper consideration of surface and bulk properties can aid in the designing of polymers for various drug-delivery applications in the healthcare industry.

The market study is broken down by Type (Natural polymers (such as cellulose, starch), Semi-synthetic polymers (such as cellulose derivatives) and Synthetic polymers (such as polyethene, polyester)), by Application (Medical Research Center, Pharmaceutical Factory and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Polymer-Based Drug Delivery market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Medtronic plc (Ireland), Allergan plc (Ireland), Pfizer, Inc. (United States), Abbott Laboratories (United States), Merck & Co., Inc. (United States), Indevus Pharmaceuticals, Inc. (United States), Boston Scientific Corporation (United States), Halozyme Therapeutics (United States), GlaxoSmithKline plc (United Kingdom) and Merck Millipore (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Polymer-Based Drug Delivery market by Type, Application and Region.

On the basis of geography, the market of Polymer-Based Drug Delivery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Releasing Pattern, the sub-segment i.e. Diffusion-controlled systems will boost the Polymer-Based Drug Delivery market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • Advancement of Drug Delivery Technology

Market Drivers
  • Increasing Adoption of Polymer-based Drug Delivery
  • Rise in the Prevalence of Chronic Diseases Such as Cancer and Diabetes

Opportunities
  • Growth in the Pharmaceutical Industry
  • Emerging Demand from Developing Countries

Restraints
  • High Cost in Medicine Development

Challenges
  • Stringent Government Rules and Regulations


Key Target Audience
Pharmaceutical Companies, Research Professionals, Emerging Companies, Distributors, Government Body & Associations and End-user

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Natural polymers (such as cellulose, starch)
  • Semi-synthetic polymers (such as cellulose derivatives)
  • Synthetic polymers (such as polyethene, polyester)
By Application
  • Medical Research Center
  • Pharmaceutical Factory
  • Others
By Releasing Pattern
  • Diffusion-controlled systems
  • Externally triggered systems
  • Chemically controlled (biodegradable) systems
  • Solvent-activated systems

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Adoption of Polymer-based Drug Delivery
      • 3.2.2. Rise in the Prevalence of Chronic Diseases Such as Cancer and Diabetes
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Advancement of Drug Delivery Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Polymer-Based Drug Delivery, by Type, Application, Releasing Pattern and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Polymer-Based Drug Delivery (Value)
      • 5.2.1. Global Polymer-Based Drug Delivery by: Type (Value)
        • 5.2.1.1. Natural polymers (such as cellulose, starch)
        • 5.2.1.2. Semi-synthetic polymers (such as cellulose derivatives)
        • 5.2.1.3. Synthetic polymers (such as polyethene, polyester)
      • 5.2.2. Global Polymer-Based Drug Delivery by: Application (Value)
        • 5.2.2.1. Medical Research Center
        • 5.2.2.2. Pharmaceutical Factory
        • 5.2.2.3. Others
      • 5.2.3. Global Polymer-Based Drug Delivery by: Releasing Pattern (Value)
        • 5.2.3.1. Diffusion-controlled systems
        • 5.2.3.2. Externally triggered systems
        • 5.2.3.3. Chemically controlled (biodegradable) systems
        • 5.2.3.4. Solvent-activated systems
      • 5.2.4. Global Polymer-Based Drug Delivery Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Polymer-Based Drug Delivery (Price)
      • 5.3.1. Global Polymer-Based Drug Delivery by: Type (Price)
  • 6. Polymer-Based Drug Delivery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Allergan plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck & Co., Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Indevus Pharmaceuticals, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boston Scientific Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Halozyme Therapeutics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GlaxoSmithKline plc (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Merck Millipore (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Polymer-Based Drug Delivery Sale, by Type, Application, Releasing Pattern and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Polymer-Based Drug Delivery (Value)
      • 7.2.1. Global Polymer-Based Drug Delivery by: Type (Value)
        • 7.2.1.1. Natural polymers (such as cellulose, starch)
        • 7.2.1.2. Semi-synthetic polymers (such as cellulose derivatives)
        • 7.2.1.3. Synthetic polymers (such as polyethene, polyester)
      • 7.2.2. Global Polymer-Based Drug Delivery by: Application (Value)
        • 7.2.2.1. Medical Research Center
        • 7.2.2.2. Pharmaceutical Factory
        • 7.2.2.3. Others
      • 7.2.3. Global Polymer-Based Drug Delivery by: Releasing Pattern (Value)
        • 7.2.3.1. Diffusion-controlled systems
        • 7.2.3.2. Externally triggered systems
        • 7.2.3.3. Chemically controlled (biodegradable) systems
        • 7.2.3.4. Solvent-activated systems
      • 7.2.4. Global Polymer-Based Drug Delivery Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Polymer-Based Drug Delivery (Price)
      • 7.3.1. Global Polymer-Based Drug Delivery by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Polymer-Based Drug Delivery: by Type(USD Million)
  • Table 2. Polymer-Based Drug Delivery Natural polymers (such as cellulose, starch) , by Region USD Million (2015-2020)
  • Table 3. Polymer-Based Drug Delivery Semi-synthetic polymers (such as cellulose derivatives) , by Region USD Million (2015-2020)
  • Table 4. Polymer-Based Drug Delivery Synthetic polymers (such as polyethene, polyester) , by Region USD Million (2015-2020)
  • Table 5. Polymer-Based Drug Delivery: by Application(USD Million)
  • Table 6. Polymer-Based Drug Delivery Medical Research Center , by Region USD Million (2015-2020)
  • Table 7. Polymer-Based Drug Delivery Pharmaceutical Factory , by Region USD Million (2015-2020)
  • Table 8. Polymer-Based Drug Delivery Others , by Region USD Million (2015-2020)
  • Table 9. Polymer-Based Drug Delivery: by Releasing Pattern(USD Million)
  • Table 10. Polymer-Based Drug Delivery Diffusion-controlled systems , by Region USD Million (2015-2020)
  • Table 11. Polymer-Based Drug Delivery Externally triggered systems , by Region USD Million (2015-2020)
  • Table 12. Polymer-Based Drug Delivery Chemically controlled (biodegradable) systems , by Region USD Million (2015-2020)
  • Table 13. Polymer-Based Drug Delivery Solvent-activated systems , by Region USD Million (2015-2020)
  • Table 14. South America Polymer-Based Drug Delivery, by Country USD Million (2015-2020)
  • Table 15. South America Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 16. South America Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 17. South America Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 18. Brazil Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 19. Brazil Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 20. Brazil Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 21. Argentina Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 22. Argentina Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 23. Argentina Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 24. Rest of South America Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 25. Rest of South America Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 26. Rest of South America Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 27. Asia Pacific Polymer-Based Drug Delivery, by Country USD Million (2015-2020)
  • Table 28. Asia Pacific Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 29. Asia Pacific Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 30. Asia Pacific Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 31. China Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 32. China Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 33. China Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 34. Japan Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 35. Japan Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 36. Japan Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 37. India Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 38. India Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 39. India Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 40. South Korea Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 41. South Korea Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 42. South Korea Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 43. Taiwan Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 44. Taiwan Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 45. Taiwan Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 46. Australia Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 47. Australia Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 48. Australia Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 52. Europe Polymer-Based Drug Delivery, by Country USD Million (2015-2020)
  • Table 53. Europe Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 54. Europe Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 55. Europe Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 56. Germany Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 57. Germany Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 58. Germany Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 59. France Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 60. France Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 61. France Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 62. Italy Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 63. Italy Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 64. Italy Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 65. United Kingdom Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 66. United Kingdom Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 67. United Kingdom Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 68. Netherlands Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 69. Netherlands Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 70. Netherlands Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 71. Rest of Europe Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 72. Rest of Europe Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 73. Rest of Europe Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 74. MEA Polymer-Based Drug Delivery, by Country USD Million (2015-2020)
  • Table 75. MEA Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 76. MEA Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 77. MEA Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 78. Middle East Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 79. Middle East Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 80. Middle East Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 81. Africa Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 82. Africa Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 83. Africa Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 84. North America Polymer-Based Drug Delivery, by Country USD Million (2015-2020)
  • Table 85. North America Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 86. North America Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 87. North America Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 88. United States Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 89. United States Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 90. United States Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 91. Canada Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 92. Canada Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 93. Canada Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 94. Mexico Polymer-Based Drug Delivery, by Type USD Million (2015-2020)
  • Table 95. Mexico Polymer-Based Drug Delivery, by Application USD Million (2015-2020)
  • Table 96. Mexico Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2015-2020)
  • Table 97. Polymer-Based Drug Delivery: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Polymer-Based Drug Delivery: by Type(USD Million)
  • Table 109. Polymer-Based Drug Delivery Natural polymers (such as cellulose, starch) , by Region USD Million (2021-2026)
  • Table 110. Polymer-Based Drug Delivery Semi-synthetic polymers (such as cellulose derivatives) , by Region USD Million (2021-2026)
  • Table 111. Polymer-Based Drug Delivery Synthetic polymers (such as polyethene, polyester) , by Region USD Million (2021-2026)
  • Table 112. Polymer-Based Drug Delivery: by Application(USD Million)
  • Table 113. Polymer-Based Drug Delivery Medical Research Center , by Region USD Million (2021-2026)
  • Table 114. Polymer-Based Drug Delivery Pharmaceutical Factory , by Region USD Million (2021-2026)
  • Table 115. Polymer-Based Drug Delivery Others , by Region USD Million (2021-2026)
  • Table 116. Polymer-Based Drug Delivery: by Releasing Pattern(USD Million)
  • Table 117. Polymer-Based Drug Delivery Diffusion-controlled systems , by Region USD Million (2021-2026)
  • Table 118. Polymer-Based Drug Delivery Externally triggered systems , by Region USD Million (2021-2026)
  • Table 119. Polymer-Based Drug Delivery Chemically controlled (biodegradable) systems , by Region USD Million (2021-2026)
  • Table 120. Polymer-Based Drug Delivery Solvent-activated systems , by Region USD Million (2021-2026)
  • Table 121. South America Polymer-Based Drug Delivery, by Country USD Million (2021-2026)
  • Table 122. South America Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 123. South America Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 124. South America Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 125. Brazil Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 126. Brazil Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 127. Brazil Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 128. Argentina Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 129. Argentina Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 130. Argentina Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 131. Rest of South America Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 132. Rest of South America Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 133. Rest of South America Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 134. Asia Pacific Polymer-Based Drug Delivery, by Country USD Million (2021-2026)
  • Table 135. Asia Pacific Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 136. Asia Pacific Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 137. Asia Pacific Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 138. China Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 139. China Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 140. China Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 141. Japan Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 142. Japan Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 143. Japan Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 144. India Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 145. India Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 146. India Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 147. South Korea Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 148. South Korea Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 149. South Korea Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 150. Taiwan Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 151. Taiwan Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 152. Taiwan Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 153. Australia Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 154. Australia Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 155. Australia Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 156. Rest of Asia-Pacific Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 157. Rest of Asia-Pacific Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 158. Rest of Asia-Pacific Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 159. Europe Polymer-Based Drug Delivery, by Country USD Million (2021-2026)
  • Table 160. Europe Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 161. Europe Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 162. Europe Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 163. Germany Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 164. Germany Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 165. Germany Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 166. France Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 167. France Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 168. France Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 169. Italy Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 170. Italy Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 171. Italy Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 172. United Kingdom Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 173. United Kingdom Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 174. United Kingdom Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 175. Netherlands Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 176. Netherlands Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 177. Netherlands Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 178. Rest of Europe Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 179. Rest of Europe Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 180. Rest of Europe Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 181. MEA Polymer-Based Drug Delivery, by Country USD Million (2021-2026)
  • Table 182. MEA Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 183. MEA Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 184. MEA Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 185. Middle East Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 186. Middle East Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 187. Middle East Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 188. Africa Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 189. Africa Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 190. Africa Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 191. North America Polymer-Based Drug Delivery, by Country USD Million (2021-2026)
  • Table 192. North America Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 193. North America Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 194. North America Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 195. United States Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 196. United States Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 197. United States Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 198. Canada Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 199. Canada Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 200. Canada Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 201. Mexico Polymer-Based Drug Delivery, by Type USD Million (2021-2026)
  • Table 202. Mexico Polymer-Based Drug Delivery, by Application USD Million (2021-2026)
  • Table 203. Mexico Polymer-Based Drug Delivery, by Releasing Pattern USD Million (2021-2026)
  • Table 204. Polymer-Based Drug Delivery: by Type(USD/Units)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Polymer-Based Drug Delivery: by Type USD Million (2015-2020)
  • Figure 5. Global Polymer-Based Drug Delivery: by Application USD Million (2015-2020)
  • Figure 6. Global Polymer-Based Drug Delivery: by Releasing Pattern USD Million (2015-2020)
  • Figure 7. South America Polymer-Based Drug Delivery Share (%), by Country
  • Figure 8. Asia Pacific Polymer-Based Drug Delivery Share (%), by Country
  • Figure 9. Europe Polymer-Based Drug Delivery Share (%), by Country
  • Figure 10. MEA Polymer-Based Drug Delivery Share (%), by Country
  • Figure 11. North America Polymer-Based Drug Delivery Share (%), by Country
  • Figure 12. Global Polymer-Based Drug Delivery: by Type USD/Units (2015-2020)
  • Figure 13. Global Polymer-Based Drug Delivery share by Players 2020 (%)
  • Figure 14. Global Polymer-Based Drug Delivery share by Players (Top 3) 2020(%)
  • Figure 15. Global Polymer-Based Drug Delivery share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 18. Medtronic plc (Ireland) Revenue: by Geography 2020
  • Figure 19. Allergan plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Allergan plc (Ireland) Revenue: by Geography 2020
  • Figure 21. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Pfizer, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 25. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Indevus Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Indevus Pharmaceuticals, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 31. Halozyme Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 32. Halozyme Therapeutics (United States) Revenue: by Geography 2020
  • Figure 33. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 35. Merck Millipore (United States) Revenue, Net Income and Gross profit
  • Figure 36. Merck Millipore (United States) Revenue: by Geography 2020
  • Figure 37. Global Polymer-Based Drug Delivery: by Type USD Million (2021-2026)
  • Figure 38. Global Polymer-Based Drug Delivery: by Application USD Million (2021-2026)
  • Figure 39. Global Polymer-Based Drug Delivery: by Releasing Pattern USD Million (2021-2026)
  • Figure 40. South America Polymer-Based Drug Delivery Share (%), by Country
  • Figure 41. Asia Pacific Polymer-Based Drug Delivery Share (%), by Country
  • Figure 42. Europe Polymer-Based Drug Delivery Share (%), by Country
  • Figure 43. MEA Polymer-Based Drug Delivery Share (%), by Country
  • Figure 44. North America Polymer-Based Drug Delivery Share (%), by Country
  • Figure 45. Global Polymer-Based Drug Delivery: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Medtronic plc (Ireland)
  • Allergan plc (Ireland)
  • Pfizer, Inc. (United States)
  • Abbott Laboratories (United States)
  • Merck & Co., Inc. (United States)
  • Indevus Pharmaceuticals, Inc. (United States)
  • Boston Scientific Corporation (United States)
  • Halozyme Therapeutics (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Merck Millipore (United States)
Select User Access Type

Key Highlights of Report


Oct 2021 211 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Polymer-Based Drug Delivery Market Quantitative research analysis
Global Polymer-Based Drug Delivery Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Medtronic plc (Ireland), Allergan plc (Ireland), Pfizer, Inc. (United States), Abbott Laboratories (United States), Merck & Co., Inc. (United States), Indevus Pharmaceuticals, Inc. (United States), Boston Scientific Corporation (United States), Halozyme Therapeutics (United States), GlaxoSmithKline plc (United Kingdom) and Merck Millipore (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Polymer-Based Drug Delivery Market to reach USD Million by 2026.

Know More About Global Polymer-Based Drug Delivery Market Report?

Have a Query? Click Here

Other Related Reports

Diabetes Care Drugs Comprehensive Study by Type (Oral Anti-diabetic drugs, Insulin, Non-insulin Injectable drugs, Combination Drugs), Application (Adults, Younger), Distribution Channel (Online, Offl...
$ 3350
Coronavirus Vaccine Comprehensive Study by Application (Hospitals, Research Laboratories, Clinics), End-users (Adults, Children) Players and Region - Global Market Outlook to 2028
$ 3500
Fluvastatin Sodium Drug Comprehensive Study by Type (Tablets, Capsules), Application (Cardiovascular Disease, Plasma Cholesterol Levels), Distribution Channel (Online, Offline), End-User (Hospital Ph...
$ 3350
Hydroxychloroquine Comprehensive Study by Type (Hydroxychloroquine 200 mg, Hydroxychloroquine 300 mg, Hydroxychloroquine 400 mg), Application (Lupus Erythematosus, Rheumatoid Arthritis, COVID-19, Oth...
$ 3650
Cervical Cancer Vaccines Comprehensive Study by Type (Gardasil, Gardasil 9, Cervarix), Application (Prostate cancer, Cervical cancer, Other), Distribution Channel (Hospitals, Clinics, Others), Treatm...
$ 3450
Pharma E-commerce Comprehensive Study by Type (Rx (prescription medicine), OTC (over the counter)), Application (Individual Use, Industrial Use) Players and Region - Global Market Outlook to 2028
$ 3500